Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

Immunological skin diseases in pigs are rare and can be caused by immune system issues or external factors.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Age-related immune changes significantly affect disease development in other systems.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.